Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Life Technologies’ Q2 Hurt by Revamping of China Sales Strategy

publication date: Aug 22, 2011
Life Technologies, the San Diego biotechnology tools company, reported its Q2 results took a 2% hit because of a restructuring of the company’s China sales strategy. During Q2, Life Technologies began to add a direct sales force in China to its existing network of independent dealers. Some dealers were eliminated. When the affected dealers heard they would not be included in the revamped network, they began destocking their Life Technologies inventory. The order slowdown reduced revenues by about $18 million. More details....

Stock Symbol: (NSDQ: LIFE)     Share this with colleagues:  

 


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital